US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Tvardi Therapeutics Inc

3.93

-0.0900-2.24%

Post-market: 3.930.00000.00%18:43 EST

Volume:53.47K

Turnover:209.41K

Market Cap:36.87M

PE:-0.50

High:4.08

Open:3.94

Low:3.83

Close:4.02

52wk High:43.65

52wk Low:3.50

Shares:9.38M

Float Shares:7.78M

Volume Ratio:1.11

T/O Rate:0.69%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-7.8700

EPS(LYR):-4.5947

ROE:-135.64%

ROA:-72.68%

PB:1.32

PE(LYR):-0.86

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Tvardi Therapeutics Inc expected to post a loss of 65 cents a share - Earnings Preview

Analysts’ Top Healthcare Picks: Inhibikase Therapeutics (IKT), Tvardi Therapeutics (TVRD)

Foghorn Therapeutics Names Ryan Maynard Chief Financial Officer

Tvardi Therapeutics to Present at Major Healthcare Investor Conferences

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/TVRD"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TVRD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TVRD\",,,,,undefined,":{"symbol":"TVRD","market":"US","secType":"STK","nameCN":"Tvardi Therapeutics Inc","latestPrice":3.93,"timestamp":1772830800000,"preClose":4.02,"halted":0,"volume":53467,"hourTrading":{"tag":"盘后","latestPrice":3.93,"preClose":3.93,"latestTime":"18:43 EST","volume":394,"amount":1547.39,"timestamp":1772840604620,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.022388059701492394,"floatShares":7778729,"shares":9381344,"eps":-7.87,"marketStatus":"Market Closed","change":-0.09,"latestTime":"03-06 16:00:00 EST","open":3.94,"high":4.08,"low":3.83,"amount":209407.1038291,"amplitude":0.062189,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-7.87,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1773043200000},"marketStatusCode":7,"adr":0,"listingDate":1391144400000,"exchange":"NASDAQ","adjPreClose":4.02,"postHourTrading":{"tag":"盘后","latestPrice":3.93,"preClose":3.93,"latestTime":"18:43 EST","volume":394,"amount":1547.39,"timestamp":1772840604620,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.106876,"impliedVol":2.3034,"impliedVolPercentile":0.6016},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TVRD\",,,,,undefined,":{"symbol":"TVRD","floatShares":7778729,"roa":"-72.68%","roe":"-135.64%","lyrEps":-4.594733,"volumeRatio":1.106876,"shares":9381344,"dividePrice":0,"high":4.08,"amplitude":0.062189,"preClose":4.02,"low":3.83,"week52Low":3.5,"pbRate":"1.32","week52High":43.65,"institutionHeld":0,"latestPrice":3.93,"eps":-7.87,"divideRate":0,"volume":53467,"delay":0,"ttmEps":-7.87,"open":3.94,"prevYearClose":4.3,"prevWeekClose":3.99,"prevMonthClose":3.99,"prevQuarterClose":4.3,"fiveDayClose":3.99,"twentyDayClose":3.55,"sixtyDayClose":4.18},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TVRD\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-13","symbol":"TVRD","fiscalQuarterEnding":"2025/09","expectedEps":-0.83,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1763010000000,"reportTimeType":"post","actualEps":-0.59},{"market":"US","date":"2025-08-14","symbol":"TVRD","fiscalQuarterEnding":"2025/06","expectedEps":-0.51,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1755144000000,"reportTimeType":"post","actualEps":1},{"market":"US","date":"2025-05-13","symbol":"TVRD","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747108800000,"reportTimeType":"post","actualEps":-3.22},{"market":"US","date":"2025-04-16","symbol":"TVRD","defaultRemindTime":1744810200000,"type":"split","dateTimestamp":1744776000000,"forFactor":3,"toFactor":1,"ratio":3},{"market":"US","date":"2025-03-11","symbol":"TVRD","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1741665600000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TVRD\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TVRD\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.25,"hold":0.5,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.25,"analysts":8,"updateTime":1770267600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TVRD\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"TVRD","date":"2026-03-05","current":-0.499365,"percent":0.75,"low":-17.054928,"twenty":-11.678936,"median":-1.80914,"eighty":-1.572682,"high":-1.408431,"avg":-5.264676,"sd":5.176148,"marketCap":37713002},"quantilePoints":[{"date":"2025-08-01","current":-6.984237,"twenty":-7.018674,"median":-6.984237,"eighty":-6.867475,"marketCap":242869870},{"date":"2025-08-08","current":-6.220168,"twenty":-7.05634,"median":-6.986928,"eighty":-6.651705,"marketCap":216300131},{"date":"2025-08-15","current":-6.400424,"twenty":-7.003609,"median":-6.690985,"eighty":-6.397734,"marketCap":222568344},{"date":"2025-08-22","current":-10.573024,"twenty":-9.576632,"median":-6.986928,"eighty":-6.42948,"marketCap":249861702},{"date":"2025-08-29","current":-12.013447,"twenty":-10.759129,"median":-7.048807,"eighty":-6.480866,"marketCap":283901784},{"date":"2025-09-05","current":-12.078921,"twenty":-11.588463,"median":-7.134899,"eighty":-6.493511,"marketCap":285449060},{"date":"2025-09-12","current":-14.047103,"twenty":-11.928926,"median":-9.803211,"eighty":-6.612426,"marketCap":331961128},{"date":"2025-09-19","current":-15.372451,"twenty":-12.457478,"median":-10.666275,"eighty":-6.823352,"marketCap":363281754},{"date":"2025-09-26","current":-14.606606,"twenty":-13.432046,"median":-11.499578,"eighty":-6.955181,"marketCap":345183308},{"date":"2025-10-03","current":-14.82882,"twenty":-14.620891,"median":-11.737664,"eighty":-6.987466,"marketCap":350434671},{"date":"2025-10-10","current":-17.054928,"twenty":-14.850248,"median":-11.943013,"eighty":-6.991233,"marketCap":403042070},{"date":"2025-10-17","current":-2.571334,"twenty":-14.850248,"median":-11.769409,"eighty":-6.823352,"marketCap":60765765},{"date":"2025-10-24","current":-2.047544,"twenty":-14.833582,"median":-11.58886,"eighty":-6.422216,"marketCap":48387554},{"date":"2025-10-31","current":-1.849138,"twenty":-14.74787,"median":-11.130543,"eighty":-4.843171,"marketCap":43698837},{"date":"2025-11-07","current":-1.563435,"twenty":-14.662953,"median":-10.195062,"eighty":-2.595143,"marketCap":36947086},{"date":"2025-11-14","current":-1.631573,"twenty":-14.620891,"median":-9.523459,"eighty":-2.06421,"marketCap":38557323},{"date":"2025-11-21","current":-1.515552,"twenty":-14.489944,"median":-7.06764,"eighty":-1.887232,"marketCap":35836734},{"date":"2025-11-28","current":-1.634574,"twenty":-14.266143,"median":-6.990963,"eighty":-1.811838,"marketCap":38651137},{"date":"2025-12-05","current":-1.658378,"twenty":-13.805842,"median":-6.911597,"eighty":-1.667399,"marketCap":39214017},{"date":"2025-12-12","current":-1.781368,"twenty":-13.436014,"median":-6.493242,"eighty":-1.662637,"marketCap":42122234},{"date":"2025-12-19","current":-1.543324,"twenty":-13.412999,"median":-6.400424,"eighty":-1.660082,"marketCap":36493428},{"date":"2025-12-26","current":-1.5949,"twenty":-13.32332,"median":-6.349307,"eighty":-1.639335,"marketCap":37713002},{"date":"2026-01-02","current":-1.705987,"twenty":-13.031267,"median":-2.777676,"eighty":-1.642509,"marketCap":40339779},{"date":"2026-01-09","current":-1.678216,"twenty":-12.62652,"median":-2.62292,"eighty":-1.634574,"marketCap":39683085},{"date":"2026-01-16","current":-1.789303,"twenty":-12.344784,"median":-2.448323,"eighty":-1.634574,"marketCap":42309861},{"date":"2026-01-23","current":-1.91626,"twenty":-12.181298,"median":-2.07532,"eighty":-1.634574,"marketCap":45311891},{"date":"2026-01-30","current":-1.547291,"twenty":-12.091222,"median":-1.95231,"eighty":-1.634574,"marketCap":36587241},{"date":"2026-02-06","current":-1.408431,"twenty":-12.026542,"median":-1.896756,"eighty":-1.617117,"marketCap":33303771},{"date":"2026-02-13","current":-1.475877,"twenty":-11.900753,"median":-1.8627,"eighty":-1.598129,"marketCap":34898599},{"date":"2026-02-20","current":-1.424301,"twenty":-11.810677,"median":-1.847154,"eighty":-1.590139,"marketCap":33679024},{"date":"2026-02-27","current":-1.606802,"twenty":-11.750362,"median":-1.836912,"eighty":-1.577443,"marketCap":37994443},{"date":"2026-03-05","current":-1.5949,"twenty":-11.678936,"median":-1.80914,"eighty":-1.572682,"marketCap":37713002}],"updateTime":1772843463590},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TVRD\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2617630918","title":"Tvardi Therapeutics Inc  expected to post a loss of 65 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2617630918","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617630918?lang=en_us&edition=fundamental","pubTime":"2026-03-07 04:39","pubTimestamp":1772829550,"startTime":"0","endTime":"0","summary":"Tvardi Therapeutics Inc  expected to post a loss of65cents a share - Earnings Preview Tvardi Therapeutics Inc TVRD.OQ TVRD.O is expected to  show a fall in quarterly revenue when it reports  results o","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260306:nL8N3ZU2IF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TVRD"],"gpt_icon":0},{"id":"2613329867","title":"Analysts’ Top Healthcare Picks: Inhibikase Therapeutics (IKT), Tvardi Therapeutics (TVRD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2613329867","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613329867?lang=en_us&edition=fundamental","pubTime":"2026-02-24 04:01","pubTimestamp":1771876883,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Inhibikase Therapeutics (IKT – Research Report) and ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-inhibikase-therapeutics-ikt-tvardi-therapeutics-tvrd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-inhibikase-therapeutics-ikt-tvardi-therapeutics-tvrd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LABU","HCSG","XLV","BK4581","LU0128526141.USD","IKT","XBI","BK4585","LU0029874061.USD","TVRD","BK4137","BK4007","BK4588"],"gpt_icon":0},{"id":"2613890237","title":"Foghorn Therapeutics Names Ryan Maynard Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2613890237","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613890237?lang=en_us&edition=fundamental","pubTime":"2026-02-23 20:00","pubTimestamp":1771848031,"startTime":"0","endTime":"0","summary":"Foghorn Therapeutics Inc. appointed Ryan Maynard as Chief Financial Officer, effective February 23, 2026. Maynard previously served as CFO at Cara Therapeutics and has more than 25 years of experience in biopharmaceutical finance and strategic transactions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Foghorn Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire  on February 23, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260223:nNDL10K2qn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314104364.USD","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","LU2095319765.USD","NDAQ","SG9999014039.USD","LU2210150020.SGD","BK4588","BK4139","LU2210149790.SGD","SG9999014021.USD","BK4007","BK4112","TVRD","IE00B64PRP62.GBP","SG9999014013.SGD","BK4585","IE00BKPKM429.USD","FHTX","SG9999014005.SGD"],"gpt_icon":0},{"id":"2610634929","title":"Tvardi Therapeutics to Present at Major Healthcare Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2610634929","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610634929?lang=en_us&edition=fundamental","pubTime":"2026-02-12 21:03","pubTimestamp":1770901381,"startTime":"0","endTime":"0","summary":"Tvardi Therapeutics Inc., a clinical-stage biopharmaceutical company focused on developing small molecule therapies targeting STAT3 for fibrosis-driven diseases, has announced its participation in several upcoming investor conferences. These include the JonesTrading C-Suite Fireside Chat Series on Wednesday, February 19, 2026, at 11:00 AM EST ; the Oppenheimer 36th Annual Healthcare Life Sciences Conference with a corporate presentation on Wednesday, February 25, 2026, at 10:40 AM EST ; the TD Cowen 46th Annual Health Care Conference with a corporate presentation on Tuesday, March 3, 2026, at 1:50 PM EST in Boston, MA; and the Barclays 28th Annual Global Healthcare Conference with a fireside chat on Tuesday, March 10, 2026, at 2:00 PM EST in Miami Beach, FL. Webcasts of the JonesTrading fireside chat and Oppenheimer presentation will be accessible on the Tvardi Investors' website, with replays available for approximately 90 days following the conferences.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260212:nNDL6MZ5rY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0550127509.SGD","LU0345770308.USD","BK5152","LU1023061713.HKD","LU0171281750.USD","LU0964806797.USD","LU0997586606.USD","LU0047473722.SGD","LU0345770993.USD","LU1023061473.USD","LU0106831901.USD","LU1078025761.USD","LU1064927863.SGD","BK4007","LU0161305163.EUR","LU1035777561.USD","LU0047473722.EUR","LU0048578792.EUR","LU0345777659.USD","LU0987226296.USD","BARC.UK","TVRD","LU1791807156.HKD","LU1668664300.SGD","LU2646069778.SGD","LU0345777147.USD"],"gpt_icon":0}],"pageSize":4,"totalPage":9,"pageCount":1,"totalSize":35,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/TVRD\",params:#limit:6,delay:false,,,undefined,":[]}}